Baader Bank Keeps a Buy Rating on Linde (LIN)

Baader Bank analyst Markus Mayer maintained a Buy rating on Linde (LINResearch Report) yesterday and set a price target of EUR327.00. The company’s shares closed last Thursday at $308.85.

According to TipRanks.com, Mayer is a 5-star analyst with an average return of 13.6% and a 64.9% success rate. Mayer covers the Basic Materials sector, focusing on stocks such as EMS-CHEMIE HOLDING AG, Wacker Chemie AG, and Clariant AG.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Linde with a $382.60 average price target, representing a 23.5% upside. In a report released today, Deutsche Bank also maintained a Buy rating on the stock with a $370.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $352.18 and a one-year low of $241.88. Currently, Linde has an average volume of 1.62M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Founded in 2017, UK-based Linde Plc is a leading global industrial gases and engineering company. The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals. Linde generates revenues through the following segments: Americas, EMEA (Europe, Middle East & Africa), APAC (Asia Pacific), Engineering and Others.

Read More on LIN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed